Glenmark Pharmaceuticals Limited (GLENMARK.NS)
INR 1541.1
(1.08%)
INR 1541.1
(1.08%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -53.22 INR | -605.41% |
| 2022 | 10.53 INR | -68.44% |
| 2021 | 33.37 INR | -2.94% |
| 2020 | 34.38 INR | 25.02% |
| 2019 | 27.50 INR | -12.97% |
| 2018 | 31.60 INR | 15.16% |
| 2017 | 27.44 INR | -15.47% |
| 2016 | 32.46 INR | 29.79% |
| 2015 | 25.01 INR | 42.75% |
| 2014 | 17.52 INR | -12.44% |
| 2013 | 20.01 INR | -12.66% |
| 2012 | 22.91 INR | 34.53% |
| 2011 | 17.03 INR | 1.49% |
| 2010 | 16.78 INR | 35.32% |
| 2009 | 12.40 INR | 61.04% |
| 2008 | 7.70 INR | -70.16% |
| 2007 | 25.80 INR | 98.61% |
| 2006 | 12.99 INR | 256.87% |
| 2005 | 3.64 INR | -18.93% |
| 2004 | 4.49 INR | 155.11% |
| 2003 | 1.76 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 12.06 INR | 127.94% |
| 2023 Q4 | -43.17 INR | -246.75% |
| 2023 Q1 | 5.31 INR | 134.98% |
| 2023 Q2 | -2.90 INR | -154.61% |
| 2023 Q3 | -12.45 INR | -329.31% |
| 2023 FY | - INR | -605.41% |
| 2022 FY | - INR | -68.44% |
| 2022 Q4 | -15.18 INR | -257.14% |
| 2022 Q1 | 6.82 INR | 23.77% |
| 2022 Q2 | 9.23 INR | 35.34% |
| 2022 Q3 | 9.66 INR | 4.66% |
| 2021 Q4 | 5.51 INR | -29.9% |
| 2021 Q1 | 10.86 INR | 31.0% |
| 2021 Q2 | 9.13 INR | -15.93% |
| 2021 FY | - INR | -2.94% |
| 2021 Q3 | 7.86 INR | -13.91% |
| 2020 Q4 | 8.29 INR | -5.8% |
| 2020 Q3 | 8.80 INR | 6.15% |
| 2020 Q1 | 9.00 INR | 15.24% |
| 2020 FY | - INR | 25.02% |
| 2020 Q2 | 8.29 INR | -7.89% |
| 2019 Q1 | 3.87 INR | -30.14% |
| 2019 Q3 | 6.76 INR | -25.39% |
| 2019 Q2 | 9.06 INR | 134.11% |
| 2019 FY | - INR | -12.97% |
| 2019 Q4 | 7.81 INR | 15.53% |
| 2018 Q4 | 5.54 INR | 34.47% |
| 2018 FY | - INR | 15.16% |
| 2018 Q3 | 4.12 INR | -71.92% |
| 2018 Q2 | 14.67 INR | 77.6% |
| 2018 Q1 | 8.26 INR | 54.39% |
| 2017 Q4 | 5.35 INR | 61.63% |
| 2017 Q2 | 7.24 INR | -38.7% |
| 2017 FY | - INR | -15.47% |
| 2017 Q1 | 11.81 INR | 1474.67% |
| 2017 Q3 | 3.31 INR | -54.28% |
| 2016 Q4 | 0.75 INR | -95.4% |
| 2016 Q3 | 16.29 INR | 109.65% |
| 2016 Q2 | 7.77 INR | 0.52% |
| 2016 Q1 | 7.73 INR | 52.47% |
| 2016 FY | - INR | 29.79% |
| 2015 Q3 | 6.95 INR | -9.27% |
| 2015 FY | - INR | 42.75% |
| 2015 Q1 | 6.91 INR | 1671.79% |
| 2015 Q2 | 7.66 INR | 10.85% |
| 2015 Q4 | 5.07 INR | -27.05% |
| 2014 Q2 | 6.09 INR | -10.7% |
| 2014 Q4 | 0.39 INR | -90.78% |
| 2014 FY | - INR | -12.44% |
| 2014 Q3 | 4.23 INR | -30.54% |
| 2014 Q1 | 6.82 INR | 345.75% |
| 2013 Q3 | 7.98 INR | 40.25% |
| 2013 FY | - INR | -12.66% |
| 2013 Q4 | 1.53 INR | -80.83% |
| 2013 Q1 | 4.75 INR | -19.63% |
| 2013 Q2 | 5.69 INR | 19.79% |
| 2012 FY | - INR | 34.53% |
| 2012 Q4 | 5.91 INR | -24.81% |
| 2012 Q2 | 5.79 INR | 100.35% |
| 2012 Q1 | 2.89 INR | -47.17% |
| 2012 Q3 | 7.86 INR | 35.75% |
| 2011 Q3 | 1.66 INR | 0.0% |
| 2011 Q4 | 5.47 INR | 229.52% |
| 2011 FY | - INR | 1.49% |
| 2010 FY | - INR | 35.32% |
| 2009 FY | - INR | 61.04% |
| 2008 FY | - INR | -70.16% |
| 2007 FY | - INR | 98.61% |
| 2006 FY | - INR | 256.87% |
| 2005 FY | - INR | -18.93% |
| 2004 FY | - INR | 155.11% |
| 2003 FY | - INR | 0.0% |